Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Denmark: COPSAC, Copenhagen Prospective Study of Childhood Asthma, researchers in Copenhagen, Denmark, noted that a higher risk...
Read Full NewsHistorical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.
New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.
Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.
1.
Getting More Done With Less Blood.
2.
A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.
3.
Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue
4.
Fear of hair loss might cause some to reject cancer treatment
5.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
1.
Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer
2.
Anemia Symptoms: What You Need to Know
3.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
4.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
5.
Unveiling the Hidden Benefits of Lymphedema Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge